Salud financiera de hoja de balance de Kilitch Drugs (India)
Salud financiera controles de criterios 5/6
Kilitch Drugs (India) tiene un patrimonio de accionistas total de ₹1.9B y una deuda total de ₹324.1M, lo que sitúa su ratio deuda-patrimonio en 17.2%. Sus activos y pasivos totales son ₹2.6B y ₹709.5M respectivamente. El BAIT de Kilitch Drugs (India) es de ₹154.0M, por lo que su ratio de cobertura de intereses es de 3.4. Tiene efectivo e inversiones a corto plazo que ascienden a ₹588.5M.
Información clave
17.2%
Ratio deuda-patrimonio
₹324.12m
Deuda
| Ratio de cobertura de intereses | 3.4x |
| Efectivo | ₹588.52m |
| Patrimonio | ₹1.88b |
| Total pasivo | ₹709.50m |
| Activos totales | ₹2.59b |
Actualizaciones recientes sobre salud financiera
Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly
Mar 05
These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Sep 08Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt
Jul 06These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Dec 17Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?
Mar 21Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?
Dec 03
Recent updates
Kilitch Drugs (India) Limited (NSE:KILITCH) Not Flying Under The Radar
Jul 23Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly
Mar 05Kilitch Drugs (India) Limited (NSE:KILITCH) Looks Just Right With A 26% Price Jump
Feb 02We Ran A Stock Scan For Earnings Growth And Kilitch Drugs (India) (NSE:KILITCH) Passed With Ease
Jan 30Investors Shouldn't Be Too Comfortable With Kilitch Drugs (India)'s (NSE:KILITCH) Earnings
Nov 17Shareholders Would Not Be Objecting To Kilitch Drugs (India) Limited's (NSE:KILITCH) CEO Compensation And Here's Why
Sep 23These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Sep 08Here's Why Kilitch Drugs (India) (NSE:KILITCH) Has Caught The Eye Of Investors
May 05Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt
Jul 06Here's Why I Think Kilitch Drugs (India) (NSE:KILITCH) Might Deserve Your Attention Today
Apr 08These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Dec 17Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?
Mar 21Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Feb 13Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?
Dec 03Does Kilitch Drugs (India) Limited (NSE:KILITCH) Have A Place In Your Dividend Stock Portfolio?
Aug 20Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jul 16Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹1.5B) de KILITCH superan a sus pasivos a corto plazo (₹707.8M).
Pasivo a largo plazo: Los activos a corto plazo de KILITCH (₹1.5B) superan a sus pasivos a largo plazo (₹1.7M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: KILITCH tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de KILITCH ha crecido de 10.9% a 17.2% en los últimos 5 años.
Cobertura de la deuda: La deuda de KILITCH está bien cubierta por el flujo de caja operativo (64.9%).
Cobertura de intereses: Los pagos de intereses de la deuda de KILITCH están bien cubiertos por el BAIT (3.4x cobertura).